Koninklijke Philips NV reported a fourth-quarter FY21 sales decline of 5.6 percent year-on-year to €4.9 billion ($5.56 billion).
The company attributed the comparable sales decline of 10 percent to headwinds caused by global supply chain challenges, postponement of equipment installations in hospitals, and consequences of the Respironics field action.
